Serotonin Receptor Type 3 Antagonists Improve Obesity-Associated Fatty Liver Disease in MiceSynia Haub, Stephan C. Bischoff, Inga Ladel et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 64